Martin Nicholson

By Admin

MN is a vaccine and biopharmaceutical manufacturing expert. He is a consultant with the World Health Organization on the mRNA technology transfer hub programme, focusing on sustainability, policy, business models and related activities. He has over 12 years’ experience in local production (LP) and previously led UNIDO’s vaccine manufacturing support activities within its global LP project. He has also worked in the biotech and pharmaceutical industry, as well as biotechnology-focused venture capital and investment banking. He has a DPhil (PhD) in immunology from Oxford University and a BSc in biochemistry from Imperial College, London.